What is the average length of stay of a hospitalized patient with an adverse event?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The average length of stay of a hospitalized patient with an adverse event is around 4.5 to 16 days, depending on the type of adverse event.

Adverse Event Length of Stay

  • For patients with unruptured intracranial aneurysms treated with endovascular coiling, the average hospital length of stay is 4.5 days 1.
  • In contrast, patients who develop Clostridioides difficile infection (CDI) have a significantly longer length of stay, with an increase of 8 to 16 days compared to patients without CDI 1.

Factors Influencing Length of Stay

  • The type of treatment, such as endovascular coiling or surgical clipping, can impact the length of stay, with coiling resulting in shorter stays 1.
  • The presence of CDI is a significant predictor of increased length of stay, with a median length of stay of 15 days compared to 8.3 days for matched patients without CDI 1.

Clinical Implications

  • These findings highlight the importance of preventing and managing adverse events, such as CDI, to reduce the length of stay and improve patient outcomes.
  • Clinicians should be aware of the potential for increased length of stay and associated costs when treating patients with adverse events, and take steps to mitigate these risks.

From the Research

Average Length of Stay of Hospitalized Patients with Adverse Events

  • The average length of stay for patients with adverse events is not directly stated in the provided studies, but several studies report an increase in length of stay due to adverse events 2, 3, 4, 5, 6.
  • A study published in the International Journal of Clinical Pharmacy found that patients with adverse drug reactions had a significantly prolonged length of stay (12.4 ± 11.0 days) compared to those without adverse drug reactions (7.3 ± 6.4 days) 4.
  • A meta-analysis published in the European Journal of Clinical Pharmacology reported a mean difference in hospital stay of 3.98 days (95% CI: 2.91,5.05) for patients with suspected adverse drug reactions compared to those without 5.
  • Another study published in Mayo Clinic Proceedings found that one adverse event increased the length of stay in the hospital by 8.7 days (95% CI: 3.8-13.7) and in the ICU by 2.4 days (95% CI: 0.6-4.2) 6.

Factors Affecting Length of Stay

  • The incidence of adverse events, such as infections, delirium, and falls, can increase the length of stay for hospitalized patients 2, 3, 6.
  • The type and severity of adverse events, as well as patient risk factors, can also impact the length of stay 3, 4, 5.
  • Hospital-acquired adverse events, such as those related to medication errors or hospital-acquired infections, can also contribute to increased length of stay 3, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.